Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C5RE | ISIN: NL0015000HT4 | Ticker-Symbol: 63E
München
20.11.24
08:15 Uhr
4,770 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ONWARD MEDICAL NV Chart 1 Jahr
5-Tage-Chart
ONWARD MEDICAL NV 5-Tage-Chart
RealtimeGeldBriefZeit
4,6104,62013:08

Aktuelle News zur ONWARD MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiONWARD Medical NV: ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke199Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke Funding...
► Artikel lesen
12.11.ONWARD Medical NV: ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights268 Company to provide update on significant milestones and near-term plans, including its recent successful financing and agreements with Ottobock and CEAEINDHOVEN, the Netherlands, Nov. 12, 2024 (GLOBE...
► Artikel lesen
04.11.Ottobock becomes Onward Medical's largest shareholder2
31.10.ONWARD Medical NV: ONWARD ARC-EX System Named One of TIME's Best Inventions of 2024261EINDHOVEN, the Netherlands, Oct. 31, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence...
► Artikel lesen
28.10.ONWARD Medical NV: ONWARD Medical Publishes Closing of Bookbuild Offering309THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Oct. 28, 2024 (GLOBE NEWSWIRE)...
► Artikel lesen
24.10.ONWARD Medical NV: ONWARD Medical Publishes Prospectus for Listing of New Shares299THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Oct. 24, 2024 This press release...
► Artikel lesen
ONWARD MEDICAL Aktie jetzt für 0€ handeln
24.10.XFRA 63E: WIEDERAUFNAHME/RESUMPTION89FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
24.10.ONWARD Medical NV: ONWARD Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA272THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Ottobock, a global leader in the fields of prosthetics, orthotics...
► Artikel lesen
23.10.XFRA 63E: AUSSETZUNG/SUSPENSION98DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILONWARD MEDICAL BV...
► Artikel lesen
22.10.ONWARD Medical NV: ONWARD Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA373NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER...
► Artikel lesen
21.10.Former Medtronic president to become board chair at Onward Medical4
21.10.ONWARD Medical NV: ONWARD Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman250Ten Hoedt is a former Medtronic President and Executive Committee Member; also a former Chairman of MedTech Europe Commercial and digital health expert Rahma Samow will also join as Director Current...
► Artikel lesen
15.10.ONWARD Medical NV: ONWARD Medical Signs Agreement with CEA for Exclusive Rights to Clinatec's WIMAGINE® Brain-Computer Interface (BCI) Technology219THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Company secures exclusive rights to incorporate the WIMAGINE...
► Artikel lesen
24.09.ONWARD Medical lists on Euronext Paris4
19.09.ONWARD Medical NV: ONWARD Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury291Company continues pioneering research on BCI-enabled system to restore mobility after spinal cord injuryEINDHOVEN, The Netherlands, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext:...
► Artikel lesen
10.09.Onward Medical N.V. reports 1H results1
10.09.ONWARD Medical NV: ONWARD Medical Reports Half Year 2024 Results and Provides a Business Update684THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Up-LIFT Study results published in Nature Medicine De Novo...
► Artikel lesen
03.09.ONWARD Medical NV: ONWARD Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System352Grant will enable ONWARD Medical, CEA-Clinatec and .NeuroRestore to evaluate the use of the ONWARD ARC-BCI System to restore thought-driven movement of the hands and arms after spinal cord injury (SCI)EINDHOVEN...
► Artikel lesen
27.08.ONWARD Medical NV: ONWARD Medical Schedules Webcast to Provide Half-Year 2024 Business Update342Company to provide more detailed commercial plans for its ARC-EX SystemEINDHOVEN, The Netherlands, Aug. 27, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company...
► Artikel lesen
05.08.ONWARD Medical NV: ONWARD Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights554Company expects to commercialize the investigational ARC-EX® System in Q4 2024 and has commenced launch preparations Company preparing to initiate global pivotal trial for investigational ARC-IM®...
► Artikel lesen
Seite:  Weiter >>
55 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1